Zimmer Holdings Inc., 345 E. Main St., Warsaw, 46580 (www.zimmer.com), through its subsidiaries designs, develops, manufactures and markets orthopedic and dental reconstructive implants, spinal implants, trauma products and other related surgical products. For the quarter ended Sept. 30, the company reported earnings of $149.9 million, or 70 cents per diluted share, on net sales of $975.6 million. Those totals compare with earnings of $214.7 million, or 95 cents per diluted share, on net sales of $952.2 million in the same period the previous year. The company’s shares trade on the New York Stock Exchange under the ticker symbol ZMH. Information for Proxy Corner was taken from Bloomberg News and from the company’s proxy statement dated March 20, 2009.